Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Positive clinical results for pramipexole in schizophrenia

May 2, 1997

Antioxidants reported by Hoechst Marion Roussel

May 2, 1997

Nippon Kayaku reports neuritogenic effects for known compound

May 2, 1997

Guidant and Neuroperfusion to further develop device for stroke

April 30, 1997

GABA-B antagonists from Novartis

April 30, 1997

Pharmacia & Upjohn prepares potent and selective dopamine D4 antagonist

April 29, 1997

SKB reports neuronal calcium channel antagonists

April 29, 1997

Sanofi describes selective NK3 receptor antagonists

April 29, 1997

Delta-opioid agonists/antagonists described by SmithKline Beecham

April 29, 1997

Parke-Davis SAR studies lead to potent, selective D4 antagonist

April 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...